Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

NCT00807144 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

End-stage Renal Failure
Graft Rejection

Interventions

DRUG: Tacrolimus (Kidney transplant maintenance immunosuppression)
DRUG: Kidney transplant maintenance immunosuppression

Sponsor

Imperial College Healthcare NHS Trust